Cited by 164Diabetes, Cardiovascular Risks, and LipoproteinsHIV-related health complications and treatmentsCardiovascular Health and Risk Factors

Metabolic Syndrome and Cardiac Disease in Japanese Men: Applicability of the Concept of Metabolic Syndrome Defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese Men-The Tanno and Sobetsu Study

Open access
TAKEUCHI, Hiroshi, SAITOH, Shigeyuki, TAKAGI, Satoru, OHNISHI, Hirofumi, OHHATA, Junichi, ISOBE, Takeshi, SHIMAMOTO, Kazuaki·2005·Hypertension Research

Abstract

Results of a 6-year follow-up study were used to determine whether the concept of and the criteria for metabolic syndrome as defined by the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) can be applied to Japanese men for prediction of the occurrence of cardiac disease. The subjects were 808 men who underwent mass health check-ups in 1993 and who were not on medication for hypertension, diabetes or hyperlipidemia. Individuals who had hypertriglyceridemia, hypo-high density lipoprotein (HDL) cholesterolemia, high blood pressure, and/or high fasting plasma glucose levels were identified on the basis of the NCEP-ATP III criteria. Not in conformity with the NCEP-ATP Ill, however, a cut-off value of 85 cm was used for waist girth as an indicator of abdominal obesity. The subjects who had 3 or more risk factors were judged as having metabolic syndrome. The proportion of subjects having metabolic syndrome was 25.3%. In the 6-year follow-up study, cardiac disease occurred in 11.7% of the subjects in the metabolic syndrome group and in 6.7% of the subjects in the non-metabolic syndrome group. Results of regression analysis using Cox's proportional hazards model showed that subjects in the metabolic syndrome group had a 2.2-times greater risk of developing cardiac disease than did subjects in the non-metabolic syndrome group. The concept of metabolic syndrome as defined in the NCEP-ATP III was therefore considered to be useful for predicting the occurrence of cardiac disease in Japanese men.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1291/hypres.28.203

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Metabolic syndrome is a condition that poses a high risk for the development of cardiovascular disease.

    “[Statement]Metabolic syndrome is a condition that poses a high risk for the development of cardiovascular disease (Evidence level: E-1b).”
  • Conditions such as metabolic syndrome that involve the clustering of multiple risk factors have been shown to increase the risk of cardiovascular diseases in epidemiological studies and meta-analyses, as well as in CIRCS study, Tanno and Sobetsu study, and Hisayama study.

    “Conditions, such as metabolic syndrome, that involve the clustering of multiple risk factors have been shown to increase the risk of cardiovascular diseases in epidemiological studies323–326) and meta-analyses327), as well as in CIRCS study78), the Tanno and Sobetsu study328) and the Hisayama study317).”
  • Metabolic syndrome is significant because it is a high risk of ASCVD even if the levels of hyperglycemia, dyslipidemia and elevated blood pressure are relatively mild.

    “Metabolic syndrome is significant because it is a high risk of ASCVD even if the levels of hyperglycemia, dyslipidemia and elevated blood pressure are relatively mild323–327).”
  • A meta-analysis of 87 clinical studies showed that the presence of metabolic syndrome results in an added risk for total mortality, coronary events, and cerebrovascular events for patients with CAD.

    “The results of a meta-analysis of 87 clinical studies have shown that the presence of metabolic syndrome results in an added risk for total mortality, coronary events, and cerebrovascular events for patients with CAD327).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Takeuchi H, Saitoh S, Takagi S, et al: Metabolic syndrome and insulin resistance in Japanese males⎯Tanno-Soubestu study. J Jpn Diab Soc 2003; 46: 739-744.
  2. Matsuzawa Y: The new diagnostic criteria of obesity. J Jpn Soc Stud Obes 2000; 6: 18-28.

Cited by

Sorted by citations

Authors
TAKEUCHI, H., SAITOH, S., TAKAGI, S., OHNISHI, H., OHHATA, J., ISOBE, T., & SHIMAMOTO, K.
Affiliations
Sapporo Medical University (JP)
Corresponding author
TAKEUCHI, Hiroshi
Venue
Hypertension Research
Published
2005
Volume
28
Issue
3
Pages
203-208
ISSN
  • 0916-9636 (ISSN-L)
  • 1348-4214
OpenAlex
W2074939007
Cited by
164
References
27
Citations by year
2026: 3 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 4 · 2016: 2 · 2015: 4 · 2014: 5 · 2013: 3 · 2012: 12
FWCI
14.98
Type
journal article
Language
en
Open access
Locations
  • Hypertension Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords
metabolic syndrome, NCEP ATP III criteria, Japanese men, cardiovascular risk, abdominal obesity, waist circumference, hypertriglyceridemia, low HDL cholesterol, hypertension, fasting blood glucose, risk prediction
MeSH terms
Aged, Follow-Up Studies, Heart Diseases, Humans, Insulin Resistance, Japan, Male, Middle Aged, Predictive Value of Tests, Prognosis, Risk Factors, Proportional Hazards Models, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review